Keros is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematologic and musculoskeletal disorders with high unmet medical need.

Sector

Manufacturing

Industry

Pharmaceutical Preparation Manufacturing

www.kerostx.com →

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance

Alerts

News

Hess Midstream: Spending Winding Down, Now Comes $850-$900 Million in Free Cash Flow

Nvidia CEO: $10 trillion company valuation absolutely possible

Cloudbreak Discovery shares climb as it details gold exploration plans in WA

Nvidia's 3 Key Catalysts Failed to Boost the Stock. This Big Hope Might.

Subsea7 Annual Report 2025

Oil Pulls Back from Highs as Leaders Seek to Calm Markets

Hyundai to recall over 61,000 Palisade SUVs in US after fatal incident, NHTSA says

RITM Stock Near 52-Week Low Despite $100 Billion in Assets and a Blowout Quarter

Oil Prices Drop From $119 High. Why They May Have Hit a Ceiling as Iran Rally Fades.

Torrid Holdings Inc. (CURV) Q4 2025 Earnings Call Transcript

Traders give 65% odds of oil holding above $100 a barrel to end of March

Spire Global: A High-Growth Space Data Platform At An Inflection Point

Lennar Corp Saw Profits Fall in Its Latest Quarter. Is It Time To Buy the Dip on This Leading Homebuilder?

KEFI Gold and Copper raises £34m in placing

Exclusive: Hiscox manager faces Greek perjury charge over extradition case

Spire Healthcare surges ahead of 'put up or shut up' deadline on rumoured Bridgeport £1B offer

Centuri's Backlog Is Booming, But Its Debt and Valuation Still Loom Large

Silicon Metals Corp. Announces Appointment of Mr. Ray Wladichuk to Chief Executive Officer

Crude Oil Trade: Defensive And Tactical Stock Buying

Work From Home, Carpool and Fly Less to Combat Soaring Oil Prices, IEA Says

About